GenEmbryomics Engages WallachBeth to Pursue Listing on a US National Stock ExchangeMELBOURNE, Australia, July 19, 2023 (GLOBE NEWSWIRE) -- GenEmbryomics, a medical genetics company with world leading intellectual property, today announced that it has retained WallachBeth Capital ("WallachBeth") as its financial advisor and investment banker to provide general financial advisory and investment banking services to the Company as it pursues a listing on a US national stock exchange.
Reproductive Geneticists Gathered in Paris Present the First-Ever Whole Genome Sequencing Test in EmbryosPARIS, April 18, 2023 (GLOBE NEWSWIRE) -- Dr. Santiago Munné, a pioneer in preimplantation genetic diagnosis, presented the first whole genome sequencing test in embryos before delegates at the 20th Conference of the Preimplantation Genetic Diagnosis International Society (PGDIS), held this week in Paris.
